Zoledronat Fresenius Onco 4 mg/5 ml
Zoledronat Fresenius Onco 4 mg/5 ml is a medicine authorised by Swissmedic under authorisation number 62481. The authorisation holder is Fresenius Kabi (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 28 September 2012 and the authorisation is valid without a time limit. ATC code M05BA08 places the medicine in the group Drugs for treatment of bone diseases.
| Authorisation number | 62481 |
|---|---|
| Name | Zoledronat Fresenius Onco 4 mg/5 ml |
| Full name | Zoledronat Fresenius Onco 4 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Fresenius Kabi (Schweiz) AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | M05BA08 |
| First authorisation | 28 September 2012 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Zoledronat Fresenius Onco 4 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung | B | 28 September 2012 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | M05BA08 | 07.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Zoledronat Fresenius Onco 4 mg/5 ml authorised in Switzerland?
Yes. Zoledronat Fresenius Onco 4 mg/5 ml is authorised by Swissmedic under authorisation number 62481, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Zoledronat Fresenius Onco 4 mg/5 ml have?
Zoledronat Fresenius Onco 4 mg/5 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Zoledronat Fresenius Onco 4 mg/5 ml?
The authorisation holder is Fresenius Kabi (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.